Quick Overview: This session took place at 7a.m. Wednesday, Dec. 11, This session took place at 3:30 p.m. Wednesday, Dec. 11, 2025. It was an Educational Session and was held in honor of the lateย ... This session occurred on Wednesday, Dec. 11,

Sabcs 2024 Targeting The Er - Detailed Overview & Context

This session took place at 7a.m. Wednesday, Dec. 11, This session took place at 3:30 p.m. Wednesday, Dec. 11, 2025. It was an Educational Session and was held in honor of the lateย ... This session occurred on Wednesday, Dec. 11, This session took place at 2 p.m. Thursday, Dec. 12, This session took place at 3:30 p.m. Wednesday, Dec. 11, 2025. It was an Educational Session. YOUTUBE CHAPTERS 0:00ย ... Dr. Aditya Bardia, MD, MPH moderates this translational session on estrogen receptor mutations and how to best

This session took place at 2 p.m. Wednesday, Dec. 11, The session took place at 7a.m. Wednesday, Dec. 11, This session took place at 12:30 p.m. on Friday, Dec. 13, This session took place at 2 p.m. on Tuesday, Dec. 10, This session took place at 7 a.m. Thursday, Dec. 12. It was a Poster Spotlight session. YOUTUBE CHAPTERS 0:00 Introduction byย ... This Plenary Lecture was given at 8:30 a.m. Thursday, Dec. 12,

This session took place at 12 p.m. on Wednesday, Dec. 11, This session took place at 7 a.m. Friday, Dec. 13, This Plenary Lecture was given at 8:30 a.m. Friday, Dec. 13, Melissa Calopiz, University of Michigan, Ann Arbor, MI, shares her unique perspective on attending the This session took place at 3 p.m. Wednesday, Dec. 11. The American Association for Cancer Research gives this award. This Educational Session took place at 3:30 p.m. on Thursday, Dec. 12,

Photo Gallery

SABCS 2024: Targeting the ER and PI3K pathway - novel drugs and combinations
SABCS 2024: Case-based clinical approach to ER Positive metastatic breast cancer
SABCS 2024: People's choice - future directions in antibody drug conjugates
SABCS 2024: Omission of Axillary Staging in ER+ Breast Cancer: Implications on Adjuvant Therapies
SABCS 2024: Unlocking new targets with molecular degraders
Full Recording | ๐—•๐—ฒ๐˜€๐˜ ๐—ผ๐—ณ ๐—ฆ๐—”๐—•๐—–๐—ฆ ๐—จ๐—”๐—˜ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ โ€“ ๐—ฆ๐—ฎ๐—ป ๐—”๐—ป๐˜๐—ผ๐—ป๐—ถ๐—ผ ๐—•๐—ฟ๐—ฒ๐—ฎ๐˜€๐˜ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐ŸŽฅ
SABCS 2023: State of the Art - Targeting Mutant ER
SABCS 2024: Translational controversies
SABCS 2024: The heart of the matter - improving adverse effects
SABCS 2024: New Directions in Breast Cancer Prevention
SABCS 2024: Clinical Workshop - Dose optimization in breast medical oncology
SABCS 2024: Survivorship - biomarker predictors and other survival associated factors
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored
Full Recording | ๐—•๐—ฒ๐˜€๐˜ ๐—ผ๐—ณ ๐—ฆ๐—”๐—•๐—–๐—ฆ ๐—จ๐—”๐—˜ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ โ€“ ๐—ฆ๐—ฎ๐—ป ๐—”๐—ป๐˜๐—ผ๐—ป๐—ถ๐—ผ ๐—•๐—ฟ๐—ฒ๐—ฎ๐˜€๐˜ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐ŸŽฅ

Full Recording | ๐—•๐—ฒ๐˜€๐˜ ๐—ผ๐—ณ ๐—ฆ๐—”๐—•๐—–๐—ฆ ๐—จ๐—”๐—˜ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ โ€“ ๐—ฆ๐—ฎ๐—ป ๐—”๐—ป๐˜๐—ผ๐—ป๐—ถ๐—ผ ๐—•๐—ฟ๐—ฒ๐—ฎ๐˜€๐˜ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐ŸŽฅ

Full Recording | Best of